TLR4: the fall guy in sepsis?

Sepsis and its impact on human health can be traced back to 1000 BC and continues to be a major health burden today. It causes about 11 million deaths world-wide of which, more than a third are due to neonatal sepsis. There is no effective treatment other than fluid resuscitation therapy and antibio...

Full description

Bibliographic Details
Main Authors: Joseph Menassa, Christina Nedeva, Corey Pollock, Hamsa Puthalakath
Format: Article
Language:English
Published: Shared Science Publishers OG 2020-11-01
Series:Cell Stress
Subjects:
Online Access:http://www.cell-stress.com/researcharticles/2020a-menassa-cell-stress/
_version_ 1819075752467890176
author Joseph Menassa
Christina Nedeva
Corey Pollock
Hamsa Puthalakath
author_facet Joseph Menassa
Christina Nedeva
Corey Pollock
Hamsa Puthalakath
author_sort Joseph Menassa
collection DOAJ
description Sepsis and its impact on human health can be traced back to 1000 BC and continues to be a major health burden today. It causes about 11 million deaths world-wide of which, more than a third are due to neonatal sepsis. There is no effective treatment other than fluid resuscitation therapy and antibiotic treatment that leave patients immunosuppressed and vulnerable to nosocomial infections. Added to that, ageing population and the emergence of antibiotic resistant bacteria pose new challenges. Most of the deleterious effects of sepsis are due to the host response to the systemic infection. In the initial phase of infection, hyper activation of the immune system leads to cytokine storm, which could lead to organ failure and this accounts for about 15% of overall deaths. However, the subsequent immune paralysis phase (mostly attributed to apoptotic death of immune cells) accounts for about 85% of all deaths. Past clinical trials (more than 100 in the last 30 years) all targeted the inflammatory phase with little success, predictably, for inflammation is a necessary process to fight infection. In order to identify the regulators of immune cell death during sepsis, we carried out an unbiased, whole genome CRISPR screening in mice and identified Trigger Receptor Expressed in Myeloid-like 4 (Treml4) as the receptor that controls both the inflammatory phase and the immune suppression phase in sepsis (Nedeva et al. (2020) Nature Immunol, doi: 10.1038/s41590-020-0789-z). Characterising the Treml4 gene knockout mice revealed new insights into the relative roles of TLR4 and TREML4 in inducing the inflammatory cytokine storm during sepsis.
first_indexed 2024-12-21T18:30:24Z
format Article
id doaj.art-2f049d1f16024aad8edbb64f93536f85
institution Directory Open Access Journal
issn 2523-0204
language English
last_indexed 2024-12-21T18:30:24Z
publishDate 2020-11-01
publisher Shared Science Publishers OG
record_format Article
series Cell Stress
spelling doaj.art-2f049d1f16024aad8edbb64f93536f852022-12-21T18:54:17ZengShared Science Publishers OGCell Stress2523-02042020-11-0141227027210.15698/cst2020.12.237TLR4: the fall guy in sepsis?Joseph Menassa0Christina Nedeva1Corey Pollock2Hamsa Puthalakath3Department of Biochemistry and Genetics, La Trobe Institute of Molecular Science, La Trobe University, Bundoora, Vic 3086, Australia.Department of Biochemistry and Genetics, La Trobe Institute of Molecular Science, La Trobe University, Bundoora, Vic 3086, Australia.Department of Biochemistry and Genetics, La Trobe Institute of Molecular Science, La Trobe University, Bundoora, Vic 3086, Australia.Department of Biochemistry and Genetics, La Trobe Institute of Molecular Science, La Trobe University, Bundoora, Vic 3086, Australia.Sepsis and its impact on human health can be traced back to 1000 BC and continues to be a major health burden today. It causes about 11 million deaths world-wide of which, more than a third are due to neonatal sepsis. There is no effective treatment other than fluid resuscitation therapy and antibiotic treatment that leave patients immunosuppressed and vulnerable to nosocomial infections. Added to that, ageing population and the emergence of antibiotic resistant bacteria pose new challenges. Most of the deleterious effects of sepsis are due to the host response to the systemic infection. In the initial phase of infection, hyper activation of the immune system leads to cytokine storm, which could lead to organ failure and this accounts for about 15% of overall deaths. However, the subsequent immune paralysis phase (mostly attributed to apoptotic death of immune cells) accounts for about 85% of all deaths. Past clinical trials (more than 100 in the last 30 years) all targeted the inflammatory phase with little success, predictably, for inflammation is a necessary process to fight infection. In order to identify the regulators of immune cell death during sepsis, we carried out an unbiased, whole genome CRISPR screening in mice and identified Trigger Receptor Expressed in Myeloid-like 4 (Treml4) as the receptor that controls both the inflammatory phase and the immune suppression phase in sepsis (Nedeva et al. (2020) Nature Immunol, doi: 10.1038/s41590-020-0789-z). Characterising the Treml4 gene knockout mice revealed new insights into the relative roles of TLR4 and TREML4 in inducing the inflammatory cytokine storm during sepsis.http://www.cell-stress.com/researcharticles/2020a-menassa-cell-stress/tlr4treml4sepsisinflammationapoptosis
spellingShingle Joseph Menassa
Christina Nedeva
Corey Pollock
Hamsa Puthalakath
TLR4: the fall guy in sepsis?
Cell Stress
tlr4
treml4
sepsis
inflammation
apoptosis
title TLR4: the fall guy in sepsis?
title_full TLR4: the fall guy in sepsis?
title_fullStr TLR4: the fall guy in sepsis?
title_full_unstemmed TLR4: the fall guy in sepsis?
title_short TLR4: the fall guy in sepsis?
title_sort tlr4 the fall guy in sepsis
topic tlr4
treml4
sepsis
inflammation
apoptosis
url http://www.cell-stress.com/researcharticles/2020a-menassa-cell-stress/
work_keys_str_mv AT josephmenassa tlr4thefallguyinsepsis
AT christinanedeva tlr4thefallguyinsepsis
AT coreypollock tlr4thefallguyinsepsis
AT hamsaputhalakath tlr4thefallguyinsepsis